Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
NCT05834478Phase 3Recruiting
- Sponsor
- Emory University
- Start
- Feb 2024
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) (2 arms), sponsored by Emory University. Primary endpoints: Change in Peak Subjective Opiate Withdrawal Scale Score at Day 3 and Safety of tcVNS use up to 7 days. Started Feb 2024; status: recruiting.
02
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05834478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834478.